Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Marcus Vinicius Santos, Andrade, Luciana Azevedo Prata, Bispo, Alan Freitas, Freitas, Luana de Alencar, Andrade, Milena Quadros Sampaio, Feitosa, Gilson Soares, Feitosa-Filho, Gilson Soares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://www.ncbi.nlm.nih.gov/pubmed/30088558
http://dx.doi.org/10.5935/abc.20180137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://www.ncbi.nlm.nih.gov/pubmed/30088558
http://dx.doi.org/10.5935/abc.20180137

Ejemplares similares